Stocks and securities in focus
| Security ▲ | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Actinium Pharmaceuticals Inc. | -3.920% | -22.008% | -15.436% | -8.548% | 25.442% | 1.250% | -11.184% |
| Alnylam Pharmace. | -0.600% | 15.164% | 9.446% | 47.746% | 40.734% | 60.658% | 255.248% |
| Applied Therapeutics Inc | 23.530% | - | - | - | - | - | - |
| Ardelyx Inc. | 7.540% | 7.309% | 13.451% | 55.899% | -3.979% | 311.111% | 152.790% |
| Bovie Medical Corp | -8.470% | -15.625% | -11.475% | -75.893% | -54.237% | -85.600% | -83.514% |
| Carisma Therapeutics Inc. | 1.100% | -4.688% | -26.875% | -81.277% | -65.493% | -98.548% | -95.499% |
| Cellectar BioSciences Inc. | -3.660% | -13.810% | -20.614% | -7.179% | -20.614% | -80.000% | - |
| Celsion Corp. | -11.300% | -1.923% | -6.422% | -9.735% | 71.429% | -92.093% | -95.444% |
| Esperion Therapeutis.Inc. | -5.600% | -15.652% | -13.956% | 26.750% | -34.373% | -84.363% | -94.593% |
| Fate Therapeutics Inc. | -8.630% | -15.342% | 39.362% | 25.199% | 19.179% | -93.965% | -76.778% |
| G1 Therapeutics | -6.170% | 0.385% | 53.704% | 85.381% | 32.800% | -74.173% | - |
| MacroGenics Inc. | -6.060% | -31.294% | -9.923% | -23.158% | -61.067% | -83.557% | -73.531% |
| Ocular Therapeutix Inc. | -3.370% | -8.170% | 14.973% | 73.720% | 69.828% | -21.692% | 61.496% |
| Puma Biotechnology Inc. | 10.940% | -0.795% | 25.125% | 0.460% | -10.474% | -39.641% | -56.797% |
| Revance Therapeutics Inc. | -2.560% | - | - | - | - | - | - |
| Sage Therapeutics Inc. | -0.460% | -7.964% | -10.289% | -73.315% | -55.970% | -74.983% | -93.987% |
| Sarepta Therapeutics | 0.530% | -1.874% | -5.554% | 36.169% | 50.882% | 133.882% | 1.505% |
| Savara Inc. | -3.300% | -1.442% | 3.535% | 28.125% | -5.093% | 301.961% | 80.458% |
| Twist Bioscience Corp | -19.780% | -26.375% | -9.993% | 88.686% | 13.955% | -61.374% | - |